MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$137,531K
Collaboration and license
agreement receivable
$5,000K
Prepaid expenses and
other current assets
$2,496K
Property and equipment
$12,645K
Total current assets
$145,027K
Operating lease
right-of-use asset
$3,959K
Property and equipment,
net
$3,892K
Restricted cash
$1,807K
Less accumulated
depreciation
$8,753K
Total assets
$154,685K
Total liabilities and
stockholders' equity
$154,685K
Total liabilities
$119,412K
Total stockholders'
equity
$35,273K
Accumulated deficit
-$418,789K
Total current
liabilities
$56,273K
Common stock warrant
liabilities
$29,560K
Deferred revenue, net of
current portion
$20,635K
Liabilities to issue common
stock
$7,333K
Operating lease
liability, net of current...
$5,611K
Additional paid-in capital
$454,062K
Deferred revenue,
current portion
$40,023K
Accrued expenses
$11,739K
Accounts payable
$3,168K
Operating lease
liability, current portion
$1,343K
Back
Back
Balance Sheet
source: myfinsight.com
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)